Clinical characteristics and treatment patterns of pregnant women with hypertension in primary care in the Federal Capital Territory of Nigeria: cross-sectional results from the hypertension treatment in Nigeria Program.

Clinical characteristics and treatment patterns of pregnant women with hypertension in primary care in the Federal Capital Territory of Nigeria: cross-sectional results from the hypertension treatment in Nigeria Program.
复制标题

DOI:
10.1186/s12884-023-05723-1
复制
发表时间:
2023-06-03
影响因子:
3.1
通讯作者:
--
中科院分区:
医学3区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

妊娠高血压疾病,包括高血压,是尼日利亚孕产妇死亡的主要原因。然而,关于在初级卫生保健机构接受护理的高血压孕妇的数据很少。本研究介绍了对参加尼日利亚高血压治疗计划的孕妇进行横断面分析的结果,该计划旨在整合和加强初级卫生保健中心的高血压护理。对尼日利亚高血压治疗计划的基线结果进行了描述性分析。对孕妇的基线血压、治疗和控制率进行了分析,并与其他育龄成年女性进行比较。进行了完整的病例分析,双侧p值 < 0.05被认为有统计学意义。 2020年1月至2022年10月期间,5972名育龄妇女在参与尼日利亚高血压治疗计划的60个初级保健中心登记,其中112名(2%)怀孕了。总体平均年龄 (SD) 为 39.6 岁 (6.3)。两组的合并症都很罕见,孕妇和非孕妇的血压相似(总体平均 (SD) 第一收缩压和舒张压为 157.4 (20.6)/100.7 (13.6) mm Hg,总体平均 (SD) 第二收缩压和舒张压为 151.7 (20.1)/98.4 (13.5) 毫米汞柱)。然而,与非孕妇相比,孕妇新诊断高血压的比例较高(65.2% vs 54.4%,p = 0.02),且基线无需预约治疗的比例较低(32.1% vs 42.1%,p = 0.03)。怀孕患者的控制率在数值上较低(6.3% vs 10.2%,p = 0.17),但没有统计学意义。一些孕妇(8.3%)正在服用妊娠禁忌药物,并且没有孕妇服用阿司匹林作为先兆子痫的一级预防。这些研究结果表明尼日利亚在护理方面存在巨大差距,也是未来研究的重要领域,以提高尼日利亚高血压孕妇的护理质量和结果,尼日利亚是全球孕产妇死亡率负担最高的国家。
Hypertensive disorders of pregnancy, including hypertension, are a leading cause of maternal mortality in Nigeria. However, there is a paucity of data on pregnant women with hypertension who receive care in primary health care facilities. This study presents the results from a cross-sectional analysis of pregnant women enrolled in the Hypertension Treatment in Nigeria Program which is aimed at integrating and strengthening hypertension care in primary health care centres. A descriptive analysis of the baseline results from the Hypertension Treatment in Nigeria Program was performed. Baseline blood pressures, treatment and control rates of pregnant women were analysed and compared to other adult women of reproductive age. A complete case analysis was performed, and a two-sided p value < 0.05 was considered statistically significant. Between January 2020 to October 2022, 5972 women of reproductive age were enrolled in the 60 primary healthcare centres participating in the Hypertension Treatment in Nigeria Program and 112 (2%) were pregnant. Overall mean age (SD) was 39.6 years (6.3). Co-morbidities were rare in both groups, and blood pressures were similar amongst pregnant and non-pregnant women (overall mean (SD) first systolic and diastolic blood pressures were 157.4 (20.6)/100.7 (13.6) mm Hg and overall mean (SD) second systolic and diastolic blood pressures were 151.7 (20.1)/98.4 (13.5) mm Hg). However, compared to non-pregnant women, pregnant women had a higher rate of newly diagnosed hypertension (65.2% versus 54.4% p = 0.02) and lower baseline walk-in treatment (32.1% versus 42.1%, p = 0.03). The control rate was numerically lower among pregnant patients (6.3% versus 10.2%, p = 0.17), but was not statistically significant. Some pregnant patients (8.3%) were on medications contraindicated in pregnancy, and none of the pregnant women were on aspirin for primary prevention of preeclampsia. These findings indicate significant gaps in care and important areas for future studies to improve the quality of care and outcomes for pregnant women with hypertension in Nigeria, a country with the highest burden of maternal mortality globally.
DOI: 10.1186/s12884-019-2319-2
发表时间: 2019-05-28
影响因子: 3.1
作者:
Gunnarsdottir, J.;Akhter, T.;Wikstrom, A. K.
通讯作者: Wikstrom, A. K.
DOI: 10.1161/hypertensionaha.120.14875
发表时间: 2020-09-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Nobles, Carrie J.;Mendola, Pauline;Schisterman, Enrique F.
通讯作者: Schisterman, Enrique F.
DOI: 10.2174/1573396316666191224092405
发表时间: 2020
影响因子: 2
作者:
Karatza AA;Dimitriou G
通讯作者: Dimitriou G
DOI: 10.1016/j.jacc.2021.02.025
发表时间: 2021-04-13
影响因子: 24
作者:
Lindley KJ;Bairey Merz CN;Davis MB;Madden T;Park K;Bello NA;American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group
通讯作者: American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group
DOI: 10.1016/j.eclinm.2022.101411
发表时间: 2022-05
期刊: EClinicalMedicine
影响因子: 15.1
作者:
通讯作者: --